Seaweed-derived Rhamnan Sulfate and Vascular Function

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Cardiovascular Diseases
Interventions
DIETARY_SUPPLEMENT

Rhamnan sulfate

A randomized, placebo-controlled, double-blind crossover dietary supplement intervention consisting of 3 weeks each of rhamnan sulfate (Rhamnox100, Konan Chemical Manufacturing Co. LTD, Mie, Japan: 540 mg/day) or placebo with 2 weeks of washout between the interventions will be conducted. Dietary supplements (rhamnan sulfate) will be taken orally three time daily at each meal time. Rhamnan sulfate is a polysaccharide (carbohydrate) extracted from seaweeds and can be considered nutrition supplement. As each pill contains 90 mg of rhamnan sulfate or placebo, subjects will be taking 2 pills before or during each meal.

Trial Locations (1)

78712

RECRUITING

Cardiovascular Aging Research Lab at UT Austin, Austin

Sponsors
All Listed Sponsors
collaborator

Konan Chemical Manufacturing

UNKNOWN

lead

University of Texas at Austin

OTHER